These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 301609)
21. Studies of the mechanisms for the induction of in vivo tumor immunity. I. Induction of primary and secondary cell-mediated cytotoxic responses by adoptive transfer of lymphocytes. Ting CC Cell Immunol; 1976 Nov; 27(1):71-81. PubMed ID: 136303 [No Abstract] [Full Text] [Related]
22. Solubilized TSTA and the major viral structural proteins, gp70 and p30, in the immune response to murine leukemias induced by Friend and Rauscher virus. Rogers MJ; Law LW; Appella E; Oroszlan S; Ting CC Int J Cancer; 1977 Aug; 20(2):303-8. PubMed ID: 892937 [TBL] [Abstract][Full Text] [Related]
23. Susceptibility of Friend virus antigen-modulated erythroleukemic cells to lysis by T lymphocytes from mice with dormant Friend virus infections. Genovesi EV; Marx PA; Wheelock EF J Immunol; 1979 Mar; 122(3):795-800. PubMed ID: 312825 [TBL] [Abstract][Full Text] [Related]
24. Macrophage-mediated in vitro sensitization of T-lymphocytes. I; Detection of murine leukemia virus-associated antigens. Treves AJ; Feldman M; Kaplan HS J Natl Cancer Inst; 1977 May; 58(5):1527-9. PubMed ID: 192905 [TBL] [Abstract][Full Text] [Related]
25. Cell-mediated immunity to leukemia associated antigens in experimental models and in man. Herberman RB Hamatol Bluttransfus; 1976; 19():195-206. PubMed ID: 188727 [No Abstract] [Full Text] [Related]
26. Immunologic tolerance to antigens associated with murine leukemia viruses: T-cell unresponsiveness? Chieco-Bianchi L; Sendo F; Aoki T; Barrera OL J Natl Cancer Inst; 1974 Apr; 52(4):1345-50. PubMed ID: 4133203 [No Abstract] [Full Text] [Related]
27. Heteroantiserum against a subpopulation of human T lymphocytes. Billing RJ; Clark W; Terasaki PI Clin Immunol Immunopathol; 1979 May; 13(1):85-91. PubMed ID: 313296 [No Abstract] [Full Text] [Related]
28. Blocking of syngeneic effector T cells by soluble tumour antigens. Plata F; Levy JP Nature; 1974 May; 249(454):271-4. PubMed ID: 4545403 [No Abstract] [Full Text] [Related]
29. In vitro cytotoxicity by a nonthymus-processed lymphocyte population with specificity for a virally determined tumor cell surface antigen. Lamon EW; Skurzak HM; Klein E; Wigzell H J Exp Med; 1972 Nov; 136(5):1072-9. PubMed ID: 4117188 [No Abstract] [Full Text] [Related]
30. Mechanism of lymphocyte-mediated cytolysis. The LMC cycle and its role in transplantation immunity. Berke G; Amos DB Transplant Rev; 1973; 17(0):71-107. PubMed ID: 4152005 [No Abstract] [Full Text] [Related]
31. Genetic alterations in tumor cells resulting in their escape from the immune response. Hyman R Cancer Chemother Rep; 1974; 58(4):431-9. PubMed ID: 4136747 [No Abstract] [Full Text] [Related]
32. Relationships between membrane antigens of human leukemic cells and oncogenic RNA virus structural components. Metzgar RS; Mohanakumar T; Bolognesi DP J Exp Med; 1976 Jan; 143(1):47-63. PubMed ID: 53269 [TBL] [Abstract][Full Text] [Related]
36. Cell-surface antigens induced by Friend and Rauscher virus complexes and their associated lymphatic leukemia viruses in the rat. Kuzumaki N; Kobayashi H Cancer Res; 1975 Jul; 35(7):1718-22. PubMed ID: 1131829 [TBL] [Abstract][Full Text] [Related]